Presentation: SB-Rabec 20 Tablet, available in Bangladesh, contains Rabeprazole Sodium 20 mg as enteric-coated tablets.

Indications: SB-Rabec (Rabeprazole) is indicated for the treatment of:  

• Active duodenal ulcer  
• Active benign gastric ulcer  
• Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)  
• Long-term management of GERD (GERD Maintenance)
• Symptomatic treatment of moderate to very severe GERD
• Zollinger-Ellison Syndrome  
• In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pyloriin patients with peptic ulcerdisease.

Dosage and Administration: SB-Rabec 20mg tablets should be swallowed whole and not chewed or crushed. For indications requiring once-daily treatment, it should be taken in the morning, before eating.

• Active Duodenal Ulcer and Active Benign Gastric Ulcer: The recommended oral dose is 20 mg once daily in the morning. Most patients with active duodenal ulcer heal within four weeks, but some may require an additional four weeks. Most patients with active benign gastric ulcer heal within six weeks, but some may require an additional six weeks.
• Erosive or Ulcerative Gastro-Esophageal Reflux Disease (GERD): The recommended oral dose is 20 mg once daily for four to eight weeks.
• GERD Maintenance: For long-term management, a maintenance dose of 20 mg or 10 mg once daily can be used depending on patient response.
• Symptomatic GERD:10 mg once daily in patients without oesophagitis. If symptom control has not been achieved during fourweeks, further investigation is needed. Once symptoms have resolved, subsequent control can be achieved using an on-demand regimen of 10 mg once daily when needed.  
• Zollinger-Ellison Syndrome:The recommended adult starting dose is 60 mg once a day. The dose may be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to 100 mg/day may be given.Doses of 120 mg/day may require divided doses, 60 mg twice daily. Treatment should continue for as long as clinically indicated.  
• Eradication of H. pylori:   The recommended combination given for 7 days is Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1g twice daily.

Side Effects: SB-Rabec (Rabeprazole) is generally well-tolerated. Common side effects may include headache, diarrhea, abdominal pain, nausea, vomiting, constipation, dry mouth, increased or decreased appetite, muscle pain, drowsiness, and dizziness. Less common side effects may include mouth sores, difficulty sleeping, flatulence, aches or back pain, and benign polyps in the stomach. Long-term use may increase the risk of bone fractures, low magnesium levels, and vitamin B12 deficiency.

Precautions: SB-Rabec (Rabeprazole) is contraindicated in patients with known hypersensitivity to Rabeprazole, other proton pump inhibitors (PPIs), or any excipients in the formulation. Gastric malignancy should be ruled out before initiating therapy. Caution should be exercised in patients with severe liver disease and during pregnancy and breastfeeding; consult your doctor before use. Inform your doctor about all other medications you are taking, as Rabeprazole can interact with certain drugs, such as ketoconazole, itraconazole, atazanavir, and methotrexate.

Storage: Store below 30°C, protected from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.